To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of Section 122(3) of the Companies Act and Paragraph 3.83(b) of the JSE Listings Requirements

Release Date: 12/02/2025 10:30
Code(s): APN     PDF:  
Wrap Text
Notification in terms of Section 122(3) of the Companies Act and Paragraph 3.83(b) of the JSE Listings Requirements

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings" or "Company")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries
(collectively "Aspen" or "the Group")



NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND PARAGRAPH 3.83(B) OF THE
JSE LISTINGS REQUIREMENTS

In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008 ("the Act") and paragraph 3.83(b)
of the JSE Listings Requirements, holders of ordinary shares in the Company are advised that the Public
Investment Corporation SOC Limited ("PIC") has formally notified the Company that it has increased its
beneficial interest in the securities of the Company to 20.157% of the ordinary share capital of the Company,
effective 7 February 2025.

Aspen has filed the notice with the Takeover Regulation Panel as required in terms of section 122(3)(a) of the
Act.

The board of directors accepts responsibility for the information contained in this announcement, and to the
best of their knowledge and belief, that information is true, and this announcement does not omit anything
likely to affect the importance of the information included.


Durban
12 February 2025


Sponsor:
Investec Bank Limited

Date: 12-02-2025 10:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.